Page 43 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Achiko Establishes Joint Venture with PT Indonesia Farma Medis for Production and Distribution ... Achiko AGFebruary 12, 2021 GMT Achiko Signs Agreement with PT Indonesia Farma Medis to Establish a New Joint Venture, including a Contract with PT Mitra Asa Pratama and a Memorandum of Understanding with PT Pharos Indonesia, Completion Subject to Formal Approvals Test Kits Will Be Integrated with Achiko...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad ... Myriad Genetics, Inc.February 12, 2021 GMT SALT LAKE CITY, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced today additional data further validating the prognostic power of its Prolaris® test and its ability to help accurat...

Press release content from Business Wire. The AP news staff was not involved in its creation. Quanterix Announces Simoa® Joint Laboratory with WuXi AppTec February 12, 2021 GMT BILLERICA, Mass.--(BUSINESS WIRE)--Feb 12, 2021-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into an agreement to open a joint Simoa laboratory with WuXi AppTec to improve access to Quanterix’ industry leading...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support ... SpyBiotechFebruary 10, 2021 GMT SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technology Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences I...

Press release content from Business Wire. The AP news staff was not involved in its creation. Repertoire Immune Medicines and Dana-Farber Cancer Institute Collaborate to Identify Novel Antigen Targets Within HPV+ Head and Neck Cancers February 11, 2021 GMT Anthony Coyle, Ph.D., President, Research and Development, Repertoire Immune Medicines (Photo: Business Wire) CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 11, 2021-- Repertoire Immune Medicines, a clinical-stage biotech company creating a new categ...

Press release content from Accesswire. The AP news staff was not involved in its creation. Relief Confirms Release of Preliminary Findings from Phase 2b/3 Trial of Intravenous RLF-100(TM) (aviptadil) February 10, 2021 GMT Initial results have been presented by Reliefs partner, NeuroRx, Inc.; additional statistical analyses remain ongoing and shall be presented when completeGENEVA, SWITZERLAND / ACCESSWIRE / February 10, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF)("Relief"), ......

Press release content from PR Newswire. The AP news staff was not involved in its creation. Zymo Research Launches COVID-19 Sequencing Service for the Detection and Surveillance of Emerging SARS-CoV-2 Variants February 11, 2021 GMT IRVINE, Calif., Feb. 10, 2021 /PRNewswire/ -- Zymo Research announced today their COVID-19 Variant Sequencing Service. This new global service expands Zymo Research’s end-to-end SARS-CoV-2 solutions that include sample collection, RNA extraction, and SARS-CoV-2 det...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ORYZON to Present New Clinical Data and Corporate Updates at Conferences in February and March Oryzon Genomics, S.A.February 10, 2021 GMT 2021 BIO CEO & Investor Digital Conference 15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021 H.C. Wainwright Global Life Sciences Conference BioCapital Europe 2021 33rd Annual ROTH Conference MADRID, Spain and CAMBRIDGE, Mass., Fe...

Press release content from Business Wire. The AP news staff was not involved in its creation. Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginstat and Pipeline Expansion February 10, 2021 GMT SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 10, 2021-- Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer’s disease on schedule to be announced in Q4 2021 and a pipeline of therapeutics for degenerative diseases, today announced a series o...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Aruvant to Participate in Numerous Scientific and Investor Conferences in February and March February 11, 2021 GMT (PRNewsfoto/Aruvant Sciences) NEW YORK and BASEL, Switzerland, Feb. 11, 2021 /PRNewswire/ -- Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene therapies for the treatment of rare diseases, today announced management participatio...